News

University of Galway, in partnership with the HRB Diabetes Collaborative Clinical Trial Network, has announced the inaugural A.Menarini Pharmaceuticals Ireland Scholarship.  The successful student is Ruth Alejandra Huerta Sinesio, originally from Mexico City, who was awarded the scholarship for her outstanding achievements and commitment to advancing diabetes research and patient care.  The A.Menarini Pharmaceuticals Ireland Scholarship, supported by Galway University Foundation, provides full financial support for a student in the Master of Science in Clinical Research.  Ruth Alejandra Huerta Sinesio was selected from a highly competitive field of candidates, demonstrating a strong dedication to improving health outcomes through her work and experience. The award will enable her to pursue advanced training and to contribute to pioneering research activities, as well as strengthening her role within the Diabetes Collaborative Clinical Trial Network and broader diabetes community.  Professor Fidelma Dunne, Director of the HRB Diabetes Collaborative Clinical Trial Network and the Institute for Clinical Trials at University of Galway, said: “We are immensely proud of Ruth Alejandra and all she has accomplished to date in her career. Her passion, drive, and commitment embody exactly what this scholarship stands for. We are deeply grateful to A.Menarini for their generous support, which enables us to nurture the next generation of clinical researchers who will make a transformative difference in Ireland and far beyond. Their investment in education and research ultimately supports the lives of people living with diabetes.”  Ruth Alejandra Huerta Sinesio said: “This scholarship motivates me to keep striving for excellence. I’m grateful to A. Menarini for this award, which supports my professional growth and my mission to address a major public health challenge. It’s an honour to be supported by a community that believes in students’ ability to improve care for people with diabetes. I hope to turn my experience and motivation into lasting impact, honouring my loved ones and improving lives worldwide.”  As part of A.Menarini Pharmaceuticals Ireland support for students at University of Galway, the company will provide three further annual scholarships in the coming years to support students demonstrating academic excellence, leadership, community engagement, or financial need. The company has also pledged support for education and training within the HRB Diabetes Collaborative Clinical Trial Network, including professional development, multidisciplinary training and expanded Patient and Public Involvement (PPI) initiatives. The investment will strengthen Ireland’s capacity to deliver world-class clinical research and foster a new generation of leaders dedicated to improving diabetes care across the globe.  Ends